FAQ

FAM46C gene

Known as: family with sequence similarity 46 member C, FAM46C, Family with Sequence Similarity 46, Member C Gene 
This gene may play a role in malignant melanoma.
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2017
024620112017

Related topics

Related topics

2 relations

Broader (1)

Genes
Neoplastic Cell Transformation

Related mentions per year

Related mentions per year

1938-2018
19401960198020002020
FAM46C gene
Neoplastic Cell Transformation
Genes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Author Correction: FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells
A correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in… (More)
Is this relevant?
2016
2016
FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer
Gastric cancer (GC) relapse can occur even if curative resection is achieved. Biomarkers predicting recurrence are needed to… (More)
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.
PURPOSE At the molecular level, myeloma is characterized by copy number abnormalities and recurrent translocations into the… (More)
Is this relevant?
2015
2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P)
Recent advances in genomic sequencing technologies now allow results from deep next-generation sequencing to be obtained within… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2014
Highly Cited
2014
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.
We performed massively parallel sequencing of paired tumor/normal samples from 203 multiple myeloma (MM) patients and identified… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients
Secondary MYC translocations in myeloma have been shown to be important in the pathogenesis and progression of disease. Here, we… (More)
Is this relevant?
2014
2014
Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma
MYC locus rearrangements—often complex combinations of translocations, insertions, deletions and inversions—in multiple myeloma… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
A diverse range of gene products are effectors of the type I interferon antiviral response.
The type I interferon response protects cells against invading viral pathogens. The cellular factors that mediate this defence… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.
PURPOSE Regions on 1p with recurrent deletions in presenting myeloma patients were examined with the purpose of defining the… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2011
2011
A diverse array of gene products are effectors of the type I interferon antiviral response
The type I interferon (IFN) response protects cells from invading viral pathogens. The cellular factors that mediate this defense… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?